Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Ulcergard Patent Expiration

Exclusivity Information

Ulcergard holds 1 exclusivity out of which 1 has expired. Details of Ulcergard's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
NCI Sep 15, 2009

Ulcergard Petitions

Details of Ulcergard's suitability petitions are listed below.

Petitioner Action Date of Action Description
Precision Consultants, Inc. Denied 18 May, 2010 The generic product will differ in strength and dosage form. The pioneer product is a 2.28 g omeprazole paste that is supplied in a 4 dose oral syringe. The proposed generic product is a 570 mg omeprazole tablet .
Intervet, Inc. Approved 28 Jan, 2005 The generic product will have a different dosage form from the pioneer.

About Ulcergard

Ulcergard is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. Ulcergard uses Omeprazole as the active ingredient.

Active Ingredient:

Ulcergard uses Omeprazole as the active ingredient. Check out other Drugs and Companies using Omeprazole ingredient.